In addition, we also observed that the majority of other subunits (NDUFB1-8/11) from the NADH dehydrogenase family have significant prognostic value (DMFS) in breast cancer patients (S1 Fig), indicating the considerable clinical value. This evidence concerns the gene ENSG00000251605 and breast carcinoma.